FBXW7 metabolic reprogramming inhibits the development of colon cancer by down-regulating the activity of arginine/mToR pathways. Li Q, Li Y, Zhou T, Zhang Y, et al. PLoS One 2025;20:e0317294.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li Q, Li Y, Zhou T, Zhang Y, et al. FBXW7 metabolic reprogramming inhibits the development of colon cancer by down-regulating the activity of arginine/mToR pathways. PLoS One 2025;20:e0317294.
PMID: 39823500